Yayın:
Protective effects of esculetin against ovary ischemia–reperfusion injury model in rats

dc.contributor.authorGüvenç, Mehmet
dc.contributor.authorYüksel, Murat
dc.contributor.authorKutlu, Tuncer
dc.contributor.authorEtyemez, Muhammed
dc.contributor.authorGökçek, İshak
dc.contributor.authorCellat, Mustafa
dc.date.accessioned2026-01-04T19:10:18Z
dc.date.issued2023-09-04
dc.description.abstractAbstractAimsOvarian ischemia–reperfusion (I/R) injury is a phenomenon that necessitates urgent intervention, which occurs as a result of ovarian torsion, and it is frequently seen in young women. A large amount of free radical and oxidative damage as a result of I/R plays a role in the cause of the incident. Antioxidant agents are thought to be beneficial in preventing this damage, and the potential protective effects of esculetin, which had not been tested previously, were investigated in this study.Study DesignThe rats in the study were divided into five groups at random: control, sham, esculetin, I/R, and treatment. Oxidative stress parameters, proinflammatory cytokines, nuclear factor erythroid 2‐related factor 2 (Nrf‐2)/nuclear factor‐kβ (NF‐κβ) pathway, and histopathological analyses were evaluated at the end of the study.Key FindingsAfter I/R, malondialdehyde levels, proinflammatory cytokines, tumor necrosis factor‐α and interleukin‐1β levels and NF‐κβ expressions were increased, Nrf‐2 expression and glutathione level decreased and the histopathologic picture deteriorated. However, as a result of the esculetin treatment, ameliorative effects in the aforementioned parameters were determined, and it was ensured that they returned to normal levels.ConclusionAccording to these findings, esculetin has protective effects on I/R damage by lowering lipid peroxidation and having antioxidant and anti‐inflammatory properties.SignificanceOur results proved the protective effect of esculetin against ovarian IR injury in rats and this may be attributed to Nrf‐2/NF‐κβ axis which showed antioxidant and anti‐inflammatory effects. Therefore, esculetin can be used in the future for preventive effects to ovarian IR injury.
dc.description.urihttps://doi.org/10.1002/jbt.23528
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/37661762
dc.identifier.doi10.1002/jbt.23528
dc.identifier.eissn1099-0461
dc.identifier.issn1095-6670
dc.identifier.openairedoi_dedup___::b8841ba2f4f5272a9c1c206f98f2df0b
dc.identifier.orcid0000-0002-9716-0697
dc.identifier.orcid0000-0001-6634-0559
dc.identifier.orcid0000-0002-0590-6405
dc.identifier.orcid0000-0003-2559-096x
dc.identifier.pubmed37661762
dc.identifier.scopus2-s2.0-85169692929
dc.identifier.urihttps://hdl.handle.net/20.500.12597/41016
dc.identifier.volume38
dc.identifier.wos001061410800001
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofJournal of Biochemical and Molecular Toxicology
dc.rightsCLOSED
dc.subjectOxidative Stress
dc.subjectTumor Necrosis Factor-alpha
dc.subjectReperfusion Injury
dc.subjectAnti-Inflammatory Agents
dc.subjectHumans
dc.subjectAnimals
dc.subjectFemale
dc.subjectOvarian Diseases
dc.subjectUmbelliferones
dc.subjectRats, Wistar
dc.subjectAntioxidants
dc.subjectRats
dc.subject.sdg3. Good health
dc.titleProtective effects of esculetin against ovary ischemia–reperfusion injury model in rats
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Mehmet Güvenç","name":"Mehmet","surname":"Güvenç","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0002-9716-0697"},"provenance":null}},{"fullName":"Murat Yüksel","name":"Murat","surname":"Yüksel","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0001-6634-0559"},"provenance":null}},{"fullName":"Tuncer Kutlu","name":"Tuncer","surname":"Kutlu","rank":3,"pid":null},{"fullName":"Muhammed Etyemez","name":"Muhammed","surname":"Etyemez","rank":4,"pid":null},{"fullName":"İshak Gökçek","name":"İshak","surname":"Gökçek","rank":5,"pid":{"id":{"scheme":"orcid","value":"0000-0002-0590-6405"},"provenance":null}},{"fullName":"Mustafa Cellat","name":"Mustafa","surname":"Cellat","rank":6,"pid":{"id":{"scheme":"orcid_pending","value":"0000-0003-2559-096x"},"provenance":null}}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"Oxidative Stress"},"provenance":null},{"subject":{"scheme":"keyword","value":"Tumor Necrosis Factor-alpha"},"provenance":null},{"subject":{"scheme":"keyword","value":"Reperfusion Injury"},"provenance":null},{"subject":{"scheme":"keyword","value":"Anti-Inflammatory Agents"},"provenance":null},{"subject":{"scheme":"keyword","value":"Humans"},"provenance":null},{"subject":{"scheme":"keyword","value":"Animals"},"provenance":null},{"subject":{"scheme":"keyword","value":"Female"},"provenance":null},{"subject":{"scheme":"keyword","value":"Ovarian Diseases"},"provenance":null},{"subject":{"scheme":"keyword","value":"Umbelliferones"},"provenance":null},{"subject":{"scheme":"keyword","value":"Rats, Wistar"},"provenance":null},{"subject":{"scheme":"keyword","value":"Antioxidants"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null},{"subject":{"scheme":"keyword","value":"Rats"},"provenance":null}],"mainTitle":"Protective effects of esculetin against ovary ischemia–reperfusion injury model in rats","subTitle":null,"descriptions":["<jats:title>Abstract</jats:title><jats:sec><jats:title>Aims</jats:title><jats:p>Ovarian ischemia–reperfusion (I/R) injury is a phenomenon that necessitates urgent intervention, which occurs as a result of ovarian torsion, and it is frequently seen in young women. A large amount of free radical and oxidative damage as a result of I/R plays a role in the cause of the incident. Antioxidant agents are thought to be beneficial in preventing this damage, and the potential protective effects of esculetin, which had not been tested previously, were investigated in this study.</jats:p></jats:sec><jats:sec><jats:title>Study Design</jats:title><jats:p>The rats in the study were divided into five groups at random: control, sham, esculetin, I/R, and treatment. Oxidative stress parameters, proinflammatory cytokines, nuclear factor erythroid 2‐related factor 2 (Nrf‐2)/nuclear factor‐kβ (NF‐κβ) pathway, and histopathological analyses were evaluated at the end of the study.</jats:p></jats:sec><jats:sec><jats:title>Key Findings</jats:title><jats:p>After I/R, malondialdehyde levels, proinflammatory cytokines, tumor necrosis factor‐α and interleukin‐1β levels and NF‐κβ expressions were increased, Nrf‐2 expression and glutathione level decreased and the histopathologic picture deteriorated. However, as a result of the esculetin treatment, ameliorative effects in the aforementioned parameters were determined, and it was ensured that they returned to normal levels.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>According to these findings, esculetin has protective effects on I/R damage by lowering lipid peroxidation and having antioxidant and anti‐inflammatory properties.</jats:p></jats:sec><jats:sec><jats:title>Significance</jats:title><jats:p>Our results proved the protective effect of esculetin against ovarian IR injury in rats and this may be attributed to Nrf‐2/NF‐κβ axis which showed antioxidant and anti‐inflammatory effects. Therefore, esculetin can be used in the future for preventive effects to ovarian IR injury.</jats:p></jats:sec>"],"publicationDate":"2023-09-04","publisher":"Wiley","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_14cb","label":"CLOSED","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Journal of Biochemical and Molecular Toxicology","issnPrinted":"1095-6670","issnOnline":"1099-0461","issnLinking":null,"ep":null,"iss":null,"sp":null,"vol":"38","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::b8841ba2f4f5272a9c1c206f98f2df0b","originalIds":["10.1002/jbt.23528","50|doiboost____|b8841ba2f4f5272a9c1c206f98f2df0b","37661762"],"pids":[{"scheme":"doi","value":"10.1002/jbt.23528"},{"scheme":"pmid","value":"37661762"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":9,"influence":2.8475653e-9,"popularity":9.178349e-9,"impulse":9,"citationClass":"C5","influenceClass":"C5","impulseClass":"C4","popularityClass":"C4"}},"instances":[{"pids":[{"scheme":"doi","value":"10.1002/jbt.23528"}],"license":"Wiley Online Library User Agreement","type":"Article","urls":["https://doi.org/10.1002/jbt.23528"],"publicationDate":"2023-09-04","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"37661762"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.1002/jbt.23528"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/37661762"],"publicationDate":"2024-01-18","refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar